Investigational VesiculoVax vaccine protects macaques against several hemorrhagic fever viruses endemic in Africa
by Press Release from Outbreak News Today on (#4TWCR)
Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa. The University of Texas Medical Branch in Galveston and Profectus BioSciences of New York are developing and testing the candidate quadrivalent VesiculoVax vaccine, with support ["]
The post Investigational VesiculoVax vaccine protects macaques against several hemorrhagic fever viruses endemic in Africa appeared first on Outbreak News Today.